Mucositis is treated and/or prevented by administrating to a patient a formulation comprising a tetracycline that is poorly absorbed from the gastro-intestinal tract. The tetracycline may be in the form of a pharmaceutically acceptable salt or a base. The formulations may optionally also contain an antifungal agent to prevent fungal overgrowth due to reduction in the normal oral flora by the tetracycline. Such compositions have the advantage of treating the entire gastro-intestinal tract since the active ingredient is not removed from the tract via absorption. Further, such compositions minimize systemic exposure and accompanying side effects.

 
Web www.patentalert.com

< Bioadhesive compositions

< Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin

> Methods for therapy of neurodegenerative disease of the brain

> Composition and treatment method for brain and spinal cord injuries

~ 00098